{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:59:47Z","timestamp":1791140387187,"version":"4.1.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12035-013-8590-8","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T10:02:59Z","timestamp":1386583379000},"page":"1181-1199","source":"Crossref","is-referenced-by-count":17,"title":["New Insight into Neurodegeneration: the Role of Proteomics"],"prefix":"10.1007","volume":"49","author":[{"given":"Ramavati","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Petter","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Geir","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"issue":"20","key":"8590_CR1","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.0b013e3182929fc3","volume":"80","author":"M Benatar","year":"2013","unstructured":"Benatar M, Wuu J, Fernandez C, Weihl CC, Katzen H, Steele J, Oskarsson B, Taylor JP (2013) Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology 80(20):1874\u20131880","journal-title":"Neurology"},{"key":"8590_CR2","doi-asserted-by":"crossref","unstructured":"Pardo LM, van Duijn CM (2005) In search of genes involved in neurodegenerative disorders. Mutat Res-Fundam Mol Mech Mutagen 592(1\u20132):89\u2013101","DOI":"10.1016\/j.mrfmmm.2005.06.006"},{"issue":"7113","key":"8590_CR3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","volume":"443","author":"CR David","year":"2006","unstructured":"David CR (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443(7113):780\u2013786","journal-title":"Nature"},{"issue":"5","key":"8590_CR4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10540-006-9028-6","volume":"26","author":"F Coppede","year":"2006","unstructured":"Coppede F, Mancuso M, Siciliano G, Migliore L, Murri L (2006) Genes and the environment in neurodegeneration. Biosci Rep 26(5):341\u2013367","journal-title":"Biosci Rep"},{"issue":"2\u20133","key":"8590_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1383-5742(02)00046-7","volume":"512","author":"L Migliore","year":"2002","unstructured":"Migliore L, Coppede F (2002) Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512(2\u20133):135\u2013153","journal-title":"Mutat Res"},{"issue":"5575","key":"8590_CR6","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1126\/science.1067122","volume":"296","author":"JP Taylor","year":"2002","unstructured":"Taylor JP, Hardy J, Fischbeck KH (2002) Biomedicine\u2014toxic proteins in neurodegenerative disease. Science 296(5575):1991\u20131995","journal-title":"Science"},{"key":"8590_CR7","first-page":"21","volume":"2013","author":"B Bjorkblom","year":"2013","unstructured":"Bjorkblom B, Adilbayeva A, Maple-Grodem J, Piston D, Okvist M, Xu XM, Brede C, Larsen JP, Moller SG (2013) The Parkinson\u2019s disease protein DJ-1 binds metals and protects against metal induced cytotoxicity. J Biol Chem 2013:21","journal-title":"J Biol Chem"},{"issue":"2","key":"8590_CR8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.1220399110","volume":"110","author":"AG Fitzmaurice","year":"2013","unstructured":"Fitzmaurice AG, Rhodes SL, Lulla A, Murphy NP, Lam HA, O\u2019Donnell KC, Barnhill L, Casida JE, Cockburn M, Sagasti A, Stahl MC, Maidment NT, Ritz B, Bronstein JM (2013) Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proc Natl Acad Sci U S A 110(2):636\u2013641","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"8590_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1440-169X.2010.01235.x","volume":"53","author":"Z Wang","year":"2011","unstructured":"Wang Z, Sugano E, Isago H, Hiroi T, Tamai M, Tomita H (2011) Differentiation of neuronal cells from NIH\/3T3 fibroblasts under defined conditions. Develop Growth Differ 53(3):357\u2013365","journal-title":"Develop Growth Differ"},{"issue":"3","key":"8590_CR10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, Brice A, Frebourg T (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65(3):664\u2013670","journal-title":"Am J Hum Genet"},{"issue":"9","key":"8590_CR11","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/jnnp.74.9.1206","volume":"74","author":"RJ Harvey","year":"2003","unstructured":"Harvey RJ, Skelton-Robinson M, Rossor MN (2003) The prevalence and causes of dementia in people under the age of 65\u00a0years. J Neurol Neurosurg Psychiatry 74(9):1206\u20131209","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"8590_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE (2008) Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9(10):768\u2013778","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"8590_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/NRL.0b013e318187e76b","volume":"15","author":"J Williamson","year":"2009","unstructured":"Williamson J, Goldman J, Marder KS (2009) Genetic aspects of Alzheimer disease. Neurologist 15(2):80\u201386","journal-title":"Neurologist"},{"issue":"1","key":"8590_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nic.2011.11.003","volume":"22","author":"CR Harrington","year":"2012","unstructured":"Harrington CR (2012) The molecular pathology of Alzheimer\u2019s disease. Neuroimaging Clin N Am 22(1):11\u201322","journal-title":"Neuroimaging Clin N Am"},{"key":"8590_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","volume":"43","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe DJ, Schenk D (2003) Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545\u2013584","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"18","key":"8590_CR16","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1523\/JNEUROSCI.18-18-07402.1998","volume":"18","author":"T Kawamata","year":"1998","unstructured":"Kawamata T, Taniguchi T, Mukai H, Kitagawa M, Hashimoto T, Maeda K, Ono Y, Tanaka C (1998) A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein. J Neurosci 18(18):7402\u20137410","journal-title":"J Neurosci"},{"issue":"9\u201310","key":"8590_CR17","first-page":"366","volume":"107","author":"M Zilkova","year":"2006","unstructured":"Zilkova M, Koson P, Zilka N (2006) The hunt for dying neurons: insight into the neuronal loss in Alzheimer\u2019s disease. Bratisl Lek Listy 107(9\u201310):366\u2013373","journal-title":"Bratisl Lek Listy"},{"issue":"6","key":"8590_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.410410606","volume":"41","author":"NL Foster","year":"1997","unstructured":"Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D\u2019Amato CJ, Gilman S (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol 41(6):706\u2013715","journal-title":"Ann Neurol"},{"key":"8590_CR19","first-page":"29","volume":"2013","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Lippa CF (2013) Clinical subtypes of frontotemporal dementia. Am J Alzheimers Dis Other Demen 2013:29","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"6","key":"8590_CR20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","volume":"26","author":"AH Schapira","year":"2011","unstructured":"Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson\u2019s disease. Mov Disord 26(6):1049\u20131055","journal-title":"Mov Disord"},{"issue":"Pt 5","key":"8590_CR21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301","journal-title":"Brain"},{"key":"8590_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"CW Olanow","year":"1999","unstructured":"Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson\u2019s disease. Annu Rev Neurosci 22:123\u2013144","journal-title":"Annu Rev Neurosci"},{"issue":"12","key":"8590_CR23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e31815bf97c","volume":"9","author":"N Pankratz","year":"2007","unstructured":"Pankratz N, Foroud T (2007) Genetics of Parkinson disease. Genet Med 9(12):801\u2013811","journal-title":"Genet Med"},{"issue":"5","key":"8590_CR24","first-page":"619","volume":"3","author":"RE Mrak","year":"2007","unstructured":"Mrak RE, Griffin WS (2007) Dementia with Lewy bodies: definition, diagnosis, and pathogenic relationship to Alzheimer\u2019s disease. Neuropsychiatr Dis Treat 3(5):619\u2013625","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"8590_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)63633-4","volume":"163","author":"DM Sampathu","year":"2003","unstructured":"Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VM (2003) Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies. Am J Pathol 163(1):91\u2013100","journal-title":"Am J Pathol"},{"issue":"21","key":"8590_CR26","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.1989.03420210056016","volume":"261","author":"J Brandt","year":"1989","unstructured":"Brandt J, Quaid KA, Folstein SE, Garber P, Maestri NE, Abbott MH, Slavney PR, Franz ML, Kasch L, Kazazian HH Jr (1989) Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington\u2019s disease. JAMA 261(21):3108\u20133114","journal-title":"JAMA"},{"issue":"11","key":"8590_CR27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.31.11.872","volume":"31","author":"K Kieburtz","year":"1994","unstructured":"Kieburtz K, MacDonald M, Shih C, Feigin A, Steinberg K, Bordwell K, Zimmerman C, Srinidhi J, Sotack J, Gusella J (1994) Trinucleotide repeat length and progression of illness in Huntington\u2019s disease. J Med Genet 31(11):872\u2013874","journal-title":"J Med Genet"},{"issue":"6","key":"8590_CR28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, MacFarlane H, Jenkins B, Anderson MA, Wexler NS, Gusella JF, Bates GP, Baxendale S, Hummerich H, Kirby S, North M, Youngman S, Mott R, Zehetner G, Sedlacek Z, Poustka A, Frischauf A-M, Lehrach H, Buckler AJ, Church D, Doucette-Stamm L, O\u2019Donovan MC, Riba-Ramirez L, Shah M, Stanton VP, Strobel SA, Draths KM, Wales JL, Dervan P, Housman DE, Altherr M, Shiang R, Thompson L, Fielder T, Wasmuth JJ, Tagle D, Valdes J, Elmer L, Allard M, Castilla L, Swaroop M, Blanchard K, Collins FS, Snell R, Holloway T, Gillespie K, Datson N, Shaw D, Harper PS (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"4","key":"8590_CR29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/WCO.0b013e3283550c97","volume":"25","author":"AD Ha","year":"2012","unstructured":"Ha AD, Fung VS (2012) Huntington\u2019s disease. Curr Opin Neurol 25(4):491\u2013498","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"8590_CR30","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(7):S10\u2013S17","journal-title":"Nat Med"},{"issue":"3","key":"8590_CR31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.410180302","volume":"18","author":"R Tandan","year":"1985","unstructured":"Tandan R, Bradley WG (1985) Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 18(3):271\u2013280","journal-title":"Ann Neurol"},{"issue":"4","key":"8590_CR32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.410180402","volume":"18","author":"R Tandan","year":"1985","unstructured":"Tandan R, Bradley WG (1985) Amyotrophic leteral sclerosis: part 2. Etiopathogenesis. Ann Neurol 18(4):419\u2013431","journal-title":"Ann Neurol"},{"issue":"22","key":"8590_CR33","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1523\/JNEUROSCI.17-22-08756.1997","volume":"17","author":"GD Ghadge","year":"1997","unstructured":"Ghadge GD, Lee JP, Bindokas VP, Jordan J, Ma L, Miller RJ, Roos RP (1997) Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci 17(22):8756\u20138766","journal-title":"J Neurosci"},{"issue":"7","key":"8590_CR34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00415-005-0742-y","volume":"252","author":"S Battistini","year":"2005","unstructured":"Battistini S, Giannini F, Greco G, Bibbo G, Ferrera L, Marini V, Causarano R, Casula M, Lando G, Patrosso MC, Caponnetto C, Origone P, Marocchi A, Del Corona A, Siciliano G, Carrera P, Mascia V, Giagheddu M, Carcassi C, Orru S, Garre C, Penco S (2005) SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study. J Neurol 252(7):782\u2013788","journal-title":"J Neurol"},{"issue":"11","key":"8590_CR35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00415-003-0235-9","volume":"250","author":"RM Berg-Vos Van Den","year":"2003","unstructured":"Van Den Berg-Vos RM, Van Den Berg LH, Visser J, de Visser M, Franssen H, Wokke JH (2003) The spectrum of lower motor neuron syndromes. J Neurol 250(11):1279\u20131292","journal-title":"J Neurol"},{"issue":"6928","key":"8590_CR36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422(6928):198\u2013207","journal-title":"Nature"},{"issue":"10","key":"8590_CR37","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1039\/c2cs15331a","volume":"41","author":"TE Angel","year":"2012","unstructured":"Angel TE, Aryal UK, Hengel SM, Baker ES, Kelly RT, Robinson EW, Smith RD (2012) Mass spectrometry-based proteomics: existing capabilities and future directions. Chem Soc Rev 41(10):3912\u20133928","journal-title":"Chem Soc Rev"},{"issue":"3","key":"8590_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bfgp\/2.3.175","volume":"2","author":"K Aggarwal","year":"2003","unstructured":"Aggarwal K, Lee KH (2003) Functional genomics and proteomics as a foundation for systems biology. Brief Funct Genomic Proteomic 2(3):175\u2013184","journal-title":"Brief Funct Genomic Proteomic"},{"issue":"4","key":"8590_CR39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cbpa.2009.06.027","volume":"13","author":"A Wolf-Yadlin","year":"2009","unstructured":"Wolf-Yadlin A, Sevecka M, MacBeath G (2009) Dissecting protein function and signaling using protein microarrays. Curr Opin Chem Biol 13(4):398\u2013405","journal-title":"Curr Opin Chem Biol"},{"issue":"5600","key":"8590_CR40","doi-asserted-by":"crossref","first-page":"1912-+","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298(5600):1912-+","journal-title":"Science"},{"issue":"9","key":"8590_CR41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2900","volume":"10","author":"W Kolch","year":"2010","unstructured":"Kolch W, Pitt A (2010) Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 10(9):618\u2013629","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"8590_CR42","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.3390\/ijms131113926","volume":"13","author":"R Savino","year":"2012","unstructured":"Savino R, Paduano S, Preiano M, Terracciano R (2012) The proteomics big challenge for biomarkers and new drug-targets discovery. Int J Mol Sci 13(11):13926\u201313948","journal-title":"Int J Mol Sci"},{"issue":"8","key":"8590_CR43","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0968-0896(98)00089-3","volume":"6","author":"N Sin","year":"1998","unstructured":"Sin N, Meng L, Auth H, Crews CM (1998) Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorg Med Chem 6(8):1209\u20131217","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"8590_CR44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth1007-785","volume":"4","author":"L Beretta","year":"2007","unstructured":"Beretta L (2007) Proteomics from the clinical perspective: many hopes and much debate. Nat Methods 4(10):785\u2013786","journal-title":"Nat Methods"},{"issue":"1","key":"8590_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1152\/physiolgenomics.00282.2007","volume":"33","author":"P Matt","year":"2008","unstructured":"Matt P, Fu Z, Fu Q, Van Eyk JE (2008) Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics 33(1):12\u201317","journal-title":"Physiol Genomics"},{"issue":"11","key":"8590_CR46","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1089\/ars.2012.4742","volume":"17","author":"DA Butterfield","year":"2012","unstructured":"Butterfield DA, Dalle-Donne I (2012) Redox proteomics. Antioxid Redox Signal 17(11):1487\u20131489","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"8590_CR47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pmic.200300435","volume":"3","author":"P Ghezzi","year":"2003","unstructured":"Ghezzi P, Bonetto V (2003) Redox proteomics: identification of oxidatively modified proteins. Proteomics 3(7):1145\u20131153","journal-title":"Proteomics"},{"issue":"14","key":"8590_CR48","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/jxb\/ern252","volume":"59","author":"S Rinalducci","year":"2008","unstructured":"Rinalducci S, Murgiano L, Zolla L (2008) Redox proteomics: basic principles and future perspectives for the detection of protein oxidation in plants. J Exp Bot 59(14):3781\u20133801","journal-title":"J Exp Bot"},{"issue":"2","key":"8590_CR49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","volume":"44","author":"W Kim","year":"2011","unstructured":"Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44(2):325\u2013340","journal-title":"Mol Cell"},{"issue":"12","key":"8590_CR50","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1074\/jbc.M110.149633","volume":"286","author":"EB Dammer","year":"2011","unstructured":"Dammer EB, Na CH, Xu P, Seyfried NT, Duong DM, Cheng D, Gearing M, Rees H, Lah JJ, Levey AI, Rush J, Peng J (2011) Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem 286(12):10457\u201310465","journal-title":"J Biol Chem"},{"issue":"11","key":"8590_CR51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm2780","volume":"10","author":"Y Ye","year":"2009","unstructured":"Ye Y, Rape M (2009) Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol 10(11):755\u2013764","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"8590_CR52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nbt849","volume":"21","author":"J Peng","year":"2003","unstructured":"Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J, Finley D, Gygi SP (2003) A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 21(8):921\u2013926","journal-title":"Nat Biotechnol"},{"key":"8590_CR53","unstructured":"Hermodson M (1996) Current protocols in protein science. In: Coligan JE, Dunn BM, Ploegh HL, Speicher DW, Wingfield PT (eds) Proteins: Structure, Function, and Bioinformatics 24 (3):409\u2013409"},{"issue":"2","key":"8590_CR54","first-page":"96","volume":"17","author":"C Yu","year":"2004","unstructured":"Yu C, Cohen L (2004) Tissue sample preparation-not the same old grind. LC GC EUR 17(2):96\u2013111","journal-title":"LC GC EUR"},{"issue":"5","key":"8590_CR55","first-page":"635","volume":"1","author":"S Hanash","year":"2001","unstructured":"Hanash S (2001) 2-D or not 2-D--is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting. Proteomics 1(5):635\u2013637","journal-title":"Proteomics"},{"issue":"11","key":"8590_CR56","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/elps.1150181133","volume":"18","author":"M \u00dcnl\u00fc","year":"1997","unstructured":"\u00dcnl\u00fc M, Morgan ME, Minden JS (1997) Difference gel electrophoresis. A single gel method for detecting changes in protein extracts. Electrophoresis 18(11):2071\u20132077","journal-title":"Electrophoresis"},{"key":"8590_CR57","doi-asserted-by":"crossref","unstructured":"Boysen RI, Hearn MTW (2001) HPLC of peptides and proteins. In: Current protocols in protein science. Wiley, New York","DOI":"10.1002\/0471140864.ps0807s23"},{"issue":"7","key":"8590_CR58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00702-012-0781-3","volume":"119","author":"A Henkel","year":"2012","unstructured":"Henkel A, M\u00fcller K, Lewczuk P, M\u00fcller T, Marcus K, Kornhuber J, Wiltfang J (2012) Multidimensional plasma protein separation technique for identification of potential Alzheimer\u2019s disease plasma biomarkers: a pilot study. J Neural Transm 119(7):779\u2013788","journal-title":"J Neural Transm"},{"issue":"3","key":"8590_CR59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/bbrc.2002.6678","volume":"292","author":"HJ Issaq","year":"2002","unstructured":"Issaq HJ, Veenstra TD, Conrads TP, Felschow D (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292(3):587\u2013592","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"8590_CR60","first-page":"3","volume":"24","author":"CS Ho","year":"2003","unstructured":"Ho CS, Lam CW, Chan MH, Cheung RC, Law LK, Lit LC, Ng KF, Suen MW, Tai HL (2003) Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev 24(1):3\u201312","journal-title":"Clin Biochem Rev"},{"issue":"8","key":"8590_CR61","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/ac0262560","volume":"75","author":"A Thompson","year":"2003","unstructured":"Thompson A, Sch\u00c3\u00a4fer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Hamon C (2003) Tandem Mass Tags:\u00e2\u20ac\u2030 a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS. Anal Chem 75(8):1895\u20131904","journal-title":"Anal Chem"},{"issue":"12","key":"8590_CR62","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","volume":"3","author":"PL Ross","year":"2004","unstructured":"Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3(12):1154\u20131169","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"8590_CR63","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","volume":"1","author":"S-E Ong","year":"2002","unstructured":"Ong S-E, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376\u2013386","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"8590_CR64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2012.01.024","volume":"234","author":"S Lehnert","year":"2012","unstructured":"Lehnert S, Jesse S, Rist W, Steinacker P, Soininen H, Herukka S-K, Tumani H, Lenter M, Oeckl P, Ferger B, Hengerer B, Otto M (2012) iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson\u2019s disease dementia. Exp Neurol 234(2):499\u2013505","journal-title":"Exp Neurol"},{"issue":"13","key":"8590_CR65","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.0.CO;2-5","volume":"21","author":"TO Joos","year":"2000","unstructured":"Joos TO, Schrenk M, Hopfl P, Kroger K, Chowdhury U, Stoll D, Schorner D, Durr M, Herick K, Rupp S, Sohn K, Hammerle H (2000) A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21(13):2641\u20132650","journal-title":"Electrophoresis"},{"issue":"8","key":"8590_CR66","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/elps.200500738","volume":"27","author":"M Fountoulakis","year":"2006","unstructured":"Fountoulakis M, Kossida S (2006) Proteomics-driven progress in neurodegeneration research. Electrophoresis 27(8):1556\u20131573","journal-title":"Electrophoresis"},{"key":"8590_CR67","first-page":"4416","volume":"13","author":"KW Li","year":"2008","unstructured":"Li KW, Smit AB (2008) Subcellular proteomics in neuroscience. Front Biosci 13:4416\u20134425","journal-title":"Front Biosci"},{"issue":"5","key":"8590_CR68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1074\/mcp.M600356-MCP200","volume":"6","author":"MC Chiang","year":"2007","unstructured":"Chiang MC, Juo CG, Chang HH, Chen HM, Yi EC, Chern Y (2007) Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach. Mol Cell Proteomics 6(5):781\u2013797","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"8590_CR69","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1096\/fj.10-157859","volume":"24","author":"P Rudrabhatla","year":"2010","unstructured":"Rudrabhatla P, Grant P, Jaffe H, Strong MJ, Pant HC (2010) Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M\/H) in Alzheimer\u2019s disease by iTRAQ. Faseb J 24(11):4396\u20134407","journal-title":"Faseb J"},{"key":"8590_CR70","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.2741\/2973","volume":"13","author":"Q Xia","year":"2008","unstructured":"Xia Q, Liao L, Cheng D, Duong DM, Gearing M, Lah JJ, Levey AI, Peng J (2008) Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci 13:3850\u20133856","journal-title":"Front Biosci"},{"issue":"1\u20132","key":"8590_CR71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","volume":"4","author":"M Hashimoto","year":"2003","unstructured":"Hashimoto M, Rockenstein E, Crews L, Masliah E (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Neuromol Med 4(1\u20132):21\u201336","journal-title":"Neuromol Med"},{"issue":"27","key":"8590_CR72","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","volume":"26","author":"C Priller","year":"2006","unstructured":"Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006) Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 26(27):7212\u20137221","journal-title":"J Neurosci"},{"issue":"1","key":"8590_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","volume":"70","author":"PR Turner","year":"2003","unstructured":"Turner PR, O\u2019Connor K, Tate WP, Abraham WC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70(1):1\u201332","journal-title":"Prog Neurobiol"},{"issue":"5","key":"8590_CR74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00018-003-3264-8","volume":"61","author":"S Ohnishi","year":"2004","unstructured":"Ohnishi S, Takano K (2004) Amyloid fibrils from the viewpoint of protein folding. Cell Mol Life Sci 61(5):511\u2013524","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"8590_CR75","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62(11):1984\u20131989","journal-title":"Neurology"},{"key":"8590_CR76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","volume":"31","author":"KJ Vos De","year":"2008","unstructured":"De Vos KJ, Grierson AJ, Ackerley S, Miller CC (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31:151\u2013173","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"8590_CR77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4161\/pri.1.2.4440","volume":"1","author":"Y Wang","year":"2007","unstructured":"Wang Y, Meriin AB, Costello CE, Sherman MY (2007) Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders. Prion 1(2):128\u2013135","journal-title":"Prion"},{"issue":"14","key":"8590_CR78","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1021\/ac060354u","volume":"78","author":"A Motoyama","year":"2006","unstructured":"Motoyama A, Venable JD, Ruse CI, Yates JR 3rd (2006) Automated ultra-high-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples. Anal Chem 78(14):5109\u20135118","journal-title":"Anal Chem"},{"issue":"45","key":"8590_CR79","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278(45):44405\u201344411","journal-title":"J Biol Chem"},{"issue":"7","key":"8590_CR80","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jprot.2012.01.014","volume":"75","author":"M Zellner","year":"2012","unstructured":"Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E (2012) Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer\u2019s disease but not in non-demented Parkinson\u2019s disease patients. J Proteomics 75(7):2080\u20132092","journal-title":"J Proteomics"},{"issue":"7","key":"8590_CR81","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jprot.2011.03.033","volume":"74","author":"F Domenico Di","year":"2011","unstructured":"Di Domenico F, Sultana R, Barone E, Perluigi M, Cini C, Mancuso C, Cai J, Pierce WM, Butterfield DA (2011) Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer\u2019s disease subjects. J Proteomics 74(7):1091\u20131103","journal-title":"J Proteomics"},{"issue":"15","key":"8590_CR82","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.jprot.2012.02.032","volume":"75","author":"V Licker","year":"2012","unstructured":"Licker V, Cote M, Lobrinus JA, Rodrigo N, Kovari E, Hochstrasser DF, Turck N, Sanchez JC, Burkhard PR (2012) Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson\u2019s disease. J Proteomics 75(15):4656\u20134667","journal-title":"J Proteomics"},{"issue":"7113","key":"8590_CR83","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"TL Michael","year":"2006","unstructured":"Michael TL, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787\u2013795","journal-title":"Nature"},{"issue":"4","key":"8590_CR84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/hh0402.105757","volume":"90","author":"MF Lopez","year":"2002","unstructured":"Lopez MF, Melov S (2002) Applied proteomics\u2014mitochondrial proteins and effect on function. Circ Res 90(4):380\u2013389","journal-title":"Circ Res"},{"issue":"4","key":"8590_CR85","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/epr.10.43","volume":"7","author":"C Rodolfo","year":"2010","unstructured":"Rodolfo C, Ciccosanti F, Giacomo GD, Piacentini M, Fimia GM (2010) Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases. Expert Rev Proteomics 7(4):519\u2013542","journal-title":"Expert Rev Proteomics"},{"issue":"16","key":"8590_CR86","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.1221132110","volume":"110","author":"ES Vincow","year":"2013","unstructured":"Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, Pallanck LJ (2013) The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci U S A 110(16):6400\u20136405","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8590_CR87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2005.10.004","volume":"22","author":"R Sultana","year":"2006","unstructured":"Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA (2006) Identification of nitrated proteins in Alzheimer\u2019s disease brain using a redox proteomics approach. Neurobiol Dis 22(1):76\u201387","journal-title":"Neurobiol Dis"},{"issue":"13","key":"8590_CR88","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1096\/fj.05-4263fje","volume":"19","author":"RL Woltjer","year":"2005","unstructured":"Woltjer RL, Cimino PJ, Boutte AM, Schantz AM, Montine KS, Larson EB, Bird T, Quinn JF, Zhang J, Montine TJ (2005) Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer\u2019s disease. Faseb J 19(13):1923\u20131925","journal-title":"Faseb J"},{"issue":"10","key":"8590_CR89","first-page":"906","volume":"24","author":"X Li","year":"2008","unstructured":"Li X, Zhang YJ, Hu Y-H, Chang M, Liu T, Wang DP, Zhang Y, Hu L-S (2008) Protein component of Lewy bodies (LBs) identified from synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells by MS analysis. Chin J Biochem Mol Biol 24(10):906\u2013915","journal-title":"Chin J Biochem Mol Biol"},{"key":"8590_CR90","doi-asserted-by":"crossref","unstructured":"Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin JH, Pan C, Shin J, Zhu D, Zhang J (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17(2):139\u2013145","DOI":"10.1111\/j.1750-3639.2007.00048.x"},{"issue":"2","key":"8590_CR91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"J Galvin","year":"2001","unstructured":"Galvin J, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58(2):186\u2013190","journal-title":"Arch Neurol"},{"issue":"2","key":"8590_CR92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160\u2013164","journal-title":"Nat Cell Biol"},{"issue":"5493","key":"8590_CR93","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"B Giasson","year":"2000","unstructured":"Giasson B, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290(5493):985\u2013989","journal-title":"Science"},{"issue":"2","key":"8590_CR94","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14789450.5.2.239","volume":"5","author":"M Fasano","year":"2008","unstructured":"Fasano M, Lopiano L (2008) Alpha-synuclein and Parkinson\u2019s disease: a proteomic view. Expert Rev Proteomics 5(2):239\u2013248","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"8590_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2008.07.003","volume":"8","author":"RA Sowell","year":"2009","unstructured":"Sowell RA, Owen JB, Butterfield DA (2009) Proteomics in animal models of Alzheimer\u2019s and Parkinson\u2019s diseases. Ageing Res Rev 8(1):1\u201317","journal-title":"Ageing Res Rev"},{"issue":"4","key":"8590_CR96","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","volume":"8","author":"C Zabel","year":"2009","unstructured":"Zabel C, Mao L, Woodman B, Rohe M, Wacker MA, Klare Y, Koppelstatter A, Nebrich G, Klein O, Grams S, Strand A, Luthi-Carter R, Hartl D, Klose J, Bates GP (2009) A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for Huntington disease. Mol Cell Proteomics 8(4):720\u2013734","journal-title":"Mol Cell Proteomics"},{"issue":"26","key":"8590_CR97","doi-asserted-by":"crossref","first-page":"21599","DOI":"10.1074\/jbc.M112.359307","volume":"287","author":"BP Culver","year":"2012","unstructured":"Culver BP, Savas JN, Park SK, Choi JH, Zheng S, Zeitlin SO, Yates JR 3rd, Tanese N (2012) Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. J Biol Chem 287(26):21599\u201321614","journal-title":"J Biol Chem"},{"issue":"4","key":"8590_CR98","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jprot.2010.12.012","volume":"74","author":"JL Chou","year":"2011","unstructured":"Chou JL, Shenoy DV, Thomas N, Choudhary PK, Laferla FM, Goodman SR, Breen GA (2011) Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer\u2019s disease. J Proteomics 74(4):466\u2013479","journal-title":"J Proteomics"},{"issue":"2","key":"8590_CR99","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-130311","volume":"36","author":"I Hong","year":"2013","unstructured":"Hong I, Kang T, Yoo Y, Park R, Lee J, Lee S, Kim J, Song B, Kim SY, Moon M, Yun KN, Kim JY, Mook-Jung I, Park YM, Choi S (2013) Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer\u2019s disease pathology. J Alzheimers Dis 36(2):321\u2013334","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"8590_CR100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1074\/mcp.M700467-MCP200","volume":"7","author":"Z Xun","year":"2008","unstructured":"Xun Z, Sowell RA, Kaufman TC, Clemmer DE (2008) Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease. Mol Cell Proteomics 7(7):1191\u20131203","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"8590_CR101","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","volume":"288","author":"CH Westphal","year":"2013","unstructured":"Westphal CH, Chandra SS (2013) Monomeric synucleins generate membrane curvature. J Biol Chem 288(3):1829\u20131840","journal-title":"J Biol Chem"},{"key":"8590_CR102","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","volume":"3","author":"R Vijitruth","year":"2006","unstructured":"Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson\u2019s disease. J Neuroinflammation 3:6","journal-title":"J Neuroinflammation"},{"issue":"3","key":"8590_CR103","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1021\/pr901024z","volume":"9","author":"X Zhang","year":"2010","unstructured":"Zhang X, Zhou JY, Chin MH, Schepmoes AA, Petyuk VA, Weitz KK, Petritis BO, Monroe ME, Camp DG, Wood SA, Melega WP, Bigelow DJ, Smith DJ, Qian WJ, Smith RD (2010) Region-specific protein abundance changes in the brain of MPTP-induced Parkinson\u2019s disease mouse model. J Proteome Res 9(3):1496\u20131509","journal-title":"J Proteome Res"},{"issue":"2","key":"8590_CR104","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/pr070546l","volume":"7","author":"MH Chin","year":"2008","unstructured":"Chin MH, Qian WJ, Wang H, Petyuk VA, Bloom JS, Sforza DM, Lacan G, Liu D, Khan AH, Cantor RM, Bigelow DJ, Melega WP, Camp DG 2nd, Smith RD, Smith DJ (2008) Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson\u2019s disease. J Proteome Res 7(2):666\u2013677","journal-title":"J Proteome Res"},{"issue":"1\u20132","key":"8590_CR105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(97)00548-9","volume":"766","author":"WP Melega","year":"1997","unstructured":"Melega WP, Raleigh MJ, Stout DB, Lacan G, Huang SC, Phelps ME (1997) Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res 766(1\u20132):113\u2013120","journal-title":"Brain Res"},{"issue":"1","key":"8590_CR106","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0006-8993(96)00995-X","volume":"738","author":"PK Sonsalla","year":"1996","unstructured":"Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED (1996) Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res 738(1):172\u2013175","journal-title":"Brain Res"},{"issue":"1\u20132","key":"8590_CR107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/prca.201200087","volume":"7","author":"JT Keeney","year":"2013","unstructured":"Keeney JT, Swomley AM, Forster S, Harris JL, Sultana R, Butterfield DA (2013) Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration. Proteomics Clin Appl 7(1\u20132):109\u2013122","journal-title":"Proteomics Clin Appl"},{"issue":"7","key":"8590_CR108","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/mds.24994","volume":"27","author":"N Ishigami","year":"2012","unstructured":"Ishigami N, Tokuda T, Ikegawa M, Komori M, Kasai T, Kondo T, Matsuyama Y, Nirasawa T, Thiele H, Tashiro K, Nakagawa M (2012) Cerebrospinal fluid proteomic patterns discriminate Parkinson\u2019s disease and multiple system atrophy. Mov Disord 27(7):851\u2013857","journal-title":"Mov Disord"},{"issue":"1","key":"8590_CR109","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/2006\/202938","volume":"22","author":"AN Fonteh","year":"2006","unstructured":"Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, Harrington MG (2006) Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers 22(1):39\u201364","journal-title":"Dis Markers"},{"issue":"33","key":"8590_CR110","doi-asserted-by":"crossref","first-page":"30359","DOI":"10.1074\/jbc.M203201200","volume":"277","author":"NG Bazan","year":"2002","unstructured":"Bazan NG, Lukiw WJ (2002) Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 277(33):30359\u201330367","journal-title":"J Biol Chem"},{"issue":"3","key":"8590_CR111","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.1997.69030889.x","volume":"69","author":"AA Farooqui","year":"1997","unstructured":"Farooqui AA, Yang HC, Rosenberger TA, Horrocks LA (1997) Phospholipase A2 and its role in brain tissue. J Neurochem 69(3):889\u2013901","journal-title":"J Neurochem"},{"issue":"9","key":"8590_CR112","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","volume":"5","author":"B Turk","year":"2006","unstructured":"Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 5(9):785\u2013799","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"8590_CR113","first-page":"3752","volume":"55","author":"F Yuan","year":"1995","unstructured":"Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55(17):3752\u20133756","journal-title":"Cancer Res"},{"issue":"5","key":"8590_CR114","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.69.5.664","volume":"69","author":"J Saez-Valero","year":"2000","unstructured":"Saez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH (2000) Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 69(5):664\u2013667","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20133","key":"8590_CR115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(02)02228-7","volume":"512","author":"F Liu","year":"2002","unstructured":"Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Merkle RK, Gong CX (2002) Role of glycosylation in hyperphosphorylation of tau in Alzheimer\u2019s disease. FEBS Lett 512(1\u20133):101\u2013106","journal-title":"FEBS Lett"},{"issue":"1","key":"8590_CR116","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archneurol.2011.642","volume":"69","author":"JM Ringman","year":"2012","unstructured":"Ringman JM, Schulman H, Becker C, Jones T, Bai Y, Immermann F, Cole G, Sokolow S, Gylys K, Geschwind DH, Cummings JL, Wan HI (2012) Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Arch Neurol 69(1):96\u2013104","journal-title":"Arch Neurol"},{"issue":"24","key":"8590_CR117","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/elps.201200307","volume":"33","author":"V Albertini","year":"2012","unstructured":"Albertini V, Benussi L, Paterlini A, Glionna M, Prestia A, Bocchio-Chiavetto L, Amicucci G, Galluzzi S, Adorni A, Geroldi C, Binetti G, Frisoni GB, Ghidoni R (2012) Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer\u2019s disease and schizophrenia. Electrophoresis 33(24):3738\u20133744","journal-title":"Electrophoresis"},{"issue":"4","key":"8590_CR118","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ymeth.2012.03.018","volume":"56","author":"D Wijte","year":"2012","unstructured":"Wijte D, McDonnell LA, Balog CI, Bossers K, Deelder AM, Swaab DF, Verhaagen J, Mayboroda OA (2012) A novel peptidomics approach to detect markers of Alzheimer\u2019s disease in cerebrospinal fluid. Methods 56(4):500\u2013507","journal-title":"Methods"},{"key":"8590_CR119","doi-asserted-by":"crossref","unstructured":"Jahn H, Wittke S, Z\u00fcrbig P, Raedler TJ, Arlt S (2011) Peptide fingerprinting of Alzheimer\u2019s disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS ONE 6(10)","DOI":"10.1371\/journal.pone.0026540"},{"issue":"2","key":"8590_CR120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2010.05.063","volume":"479","author":"X Zhao","year":"2010","unstructured":"Zhao X, Xiao WZ, Pu XP, Zhong LJ (2010) Proteome analysis of the sera from Chinese Parkinson\u2019s disease patients. Neurosci Lett 479(2):175\u2013179","journal-title":"Neurosci Lett"},{"issue":"5\u20136","key":"8590_CR121","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2011.01.002","volume":"44","author":"HM Chen","year":"2011","unstructured":"Chen HM, Lin CY, Wang V (2011) Amyloid P component as a plasma marker for Parkinson\u2019s disease identified by a proteomic approach. Clin Biochem 44(5\u20136):377\u2013385","journal-title":"Clin Biochem"},{"key":"8590_CR122","doi-asserted-by":"crossref","unstructured":"Sinha A, Srivastava N, Singh S, Singh AK, Bhushan S, Shukla R, Singh MP (2009) Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson\u2019s disease patients: A proteomic approach. Clin Chim Acta 400(1\u20132):14\u201320","DOI":"10.1016\/j.cca.2008.09.026"},{"issue":"2","key":"8590_CR123","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1039\/C1AN15551B","volume":"137","author":"X Zhang","year":"2012","unstructured":"Zhang X, Yin X, Yu H, Liu X, Yang F, Yao J, Jin H, Yang P (2012) Quantitative proteomic analysis of serum proteins in patients with Parkinson\u2019s disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. Analyst 137(2):490\u2013495","journal-title":"Analyst"},{"issue":"2","key":"8590_CR124","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/pr700630x","volume":"7","author":"S Pan","year":"2008","unstructured":"Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T (2008) Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption\/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF\/TOF) platform. J Proteome Res 7(2):720\u2013730","journal-title":"J Proteome Res"},{"issue":"Pt 3","key":"8590_CR125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133(Pt 3):713\u2013726","journal-title":"Brain"},{"issue":"3","key":"8590_CR126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","volume":"24","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G, Heutink P (2003) DJ-1(PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24(3):159\u2013160","journal-title":"Neurol Sci"},{"issue":"2","key":"8590_CR127","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","volume":"5","author":"T Taira","year":"2004","unstructured":"Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5(2):213\u2013218","journal-title":"EMBO Rep"},{"issue":"1","key":"8590_CR128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease. Neurosci Lett 480(1):78\u201382","journal-title":"Neurosci Lett"},{"key":"8590_CR129","doi-asserted-by":"crossref","unstructured":"Lin X, Cook T, Zabetian C, Leverenz J, Peskind E, Hu S, Cain K, Pan C, Edgar J, Goodlett D, Racette B, Checkoway H, Montine T, Shi M, Zhang J (2012) DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep 2(954)","DOI":"10.1038\/srep00954"},{"issue":"2","key":"8590_CR130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000323427","volume":"65","author":"YH Li","year":"2011","unstructured":"Li YH, Wang J, Zheng XL, Zhang YL, Li X, Yu S, He X, Chan P (2011) Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson\u2019s disease. Eur Neurol 65(2):105\u2013111","journal-title":"Eur Neurol"},{"issue":"7","key":"8590_CR131","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP, Leavitt BR, Keir G, Ward M, Tabrizi SJ (2007) Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6(7):2833\u20132840","journal-title":"J Proteome Res"},{"issue":"1","key":"8590_CR132","doi-asserted-by":"crossref","first-page":"0015809","DOI":"10.1371\/journal.pone.0015809","volume":"6","author":"YC Huang","year":"2011","unstructured":"Huang YC, Wu YR, Tseng MY, Chen YC, Hsieh SY, Chen CM (2011) Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington\u2019s disease. PLoS ONE 6(1):0015809","journal-title":"PLoS ONE"},{"issue":"5","key":"8590_CR133","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.2005.03478.x","volume":"95","author":"S Ranganathan","year":"2005","unstructured":"Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH Jr, Bowser R (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 95(5):1461\u20131471","journal-title":"J Neurochem"},{"issue":"8","key":"8590_CR134","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","volume":"66","author":"GM Pasinetti","year":"2006","unstructured":"Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L (2006) Identification of potential CSF biomarkers in ALS. Neurology 66(8):1218\u20131222","journal-title":"Neurology"},{"issue":"1","key":"8590_CR135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2009.10.053","volume":"468","author":"J Brettschneider","year":"2010","unstructured":"Brettschneider J, Lehmensiek V, Mogel H, Pfeifle M, Dorst J, Hendrich C, Ludolph AC, Tumani H (2010) Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett 468(1):23\u201327","journal-title":"Neurosci Lett"},{"issue":"8","key":"8590_CR136","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.parkreldis.2010.06.011","volume":"16","author":"R Constantinescu","year":"2010","unstructured":"Constantinescu R, Andreasson U, Li S, Podust VN, Mattsson N, Anckarsater R, Anckarsater H, Rosengren L, Holmberg B, Blennow K, Wikkelso C, Ruetschi U, Zetterberg H (2010) Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord 16(8):545\u2013549","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"8590_CR137","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/nprot.2008.150","volume":"3","author":"J Villen","year":"2008","unstructured":"Villen J, Gygi SP (2008) The SCX\/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protoc 3(10):1630\u20131638","journal-title":"Nat Protoc"},{"issue":"14","key":"8590_CR138","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/elps.200500026","volume":"26","author":"T Stasyk","year":"2005","unstructured":"Stasyk T, Morandell S, Bakry R, Feuerstein I, Huck CW, Stecher G, Bonn GK, Huber LA (2005) Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining. Electrophoresis 26(14):2850\u20132854","journal-title":"Electrophoresis"},{"issue":"7","key":"8590_CR139","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/pmic.200300434","volume":"3","author":"TH Steinberg","year":"2003","unstructured":"Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T, Schulenberg B, Hendrickson J, Beechem JM, Haugland RP, Patton WF (2003) Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 3(7):1128\u20131144","journal-title":"Proteomics"},{"issue":"1","key":"8590_CR140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1074\/mcp.M500226-MCP200","volume":"5","author":"C D\u2019Ambrosio","year":"2006","unstructured":"D\u2019Ambrosio C, Arena S, Fulcoli G, Scheinfeld MH, Zhou D, D\u2019Adamio L, Scaloni A (2006) Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease. Mol Cell Proteomics 5(1):97\u2013113","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"8590_CR141","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-4159.2012.07737.x","volume":"121","author":"S Zahid","year":"2012","unstructured":"Zahid S, Oellerich M, Asif AR, Ahmed N (2012) Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer\u2019s disease patients. J Neurochem 121(6):954\u2013963","journal-title":"J Neurochem"},{"issue":"14","key":"8590_CR142","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00018-004-4104-1","volume":"61","author":"V Bonifati","year":"2004","unstructured":"Bonifati V, Oostra BA, Heutink P (2004) Unraveling the pathogenesis of Parkinson\u2019s disease - the contribution of monogenic forms. Cell Mol Life Sci 61(14):1729\u20131750","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"8590_CR143","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","volume":"18","author":"T Gasser","year":"2005","unstructured":"Gasser T (2005) Genetics of Parkinson\u2019s disease. Curr Opin Neurol 18(4):363\u2013369","journal-title":"Curr Opin Neurol"},{"key":"8590_CR144","unstructured":"Golbe LI (2003) Alpha-synuclein and Parkinson\u2019s disease. In: Gordin A, Kaakkola S, Teravainen H (eds) Parkinson\u2019s Disease, vol 91. Advances in Neurology. pp 165\u2013174"},{"issue":"4","key":"8590_CR145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.21022","volume":"60","author":"J Hardy","year":"2006","unstructured":"Hardy J, Cai HB, Cookson MR, Gwinn-Hardy K, Singleton A (2006) Genetics of Parkinson\u2019s disease and parkinsonism. Ann Neurol 60(4):389\u2013398","journal-title":"Ann Neurol"},{"issue":"12","key":"8590_CR146","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Pathogenesis of Parkinson\u2019s disease: Dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3(12):932\u2013942","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"8590_CR147","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/nbdi.2000.0319","volume":"7","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Dawson VL, Dawson TM (2000) Oxidative stress and genetics in the pathogenesis of Parkinson\u2019s disease. Neurobiol Dis 7(4):240\u2013250","journal-title":"Neurobiol Dis"},{"issue":"4","key":"8590_CR148","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/319522","volume":"68","author":"E Valente","year":"2001","unstructured":"Valente E, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, Albanese A, Wood NW (2001) Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 68(4):895\u2013900","journal-title":"Am J Hum Genet"},{"issue":"5674","key":"8590_CR149","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonaldo R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304(5674):1158\u20131160","journal-title":"Science"},{"issue":"3","key":"8590_CR150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51(3):296\u2013301","journal-title":"Ann Neurol"},{"issue":"22","key":"8590_CR151","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","volume":"276","author":"U Kumari","year":"2009","unstructured":"Kumari U, Tan EK (2009) LRRK2 in Parkinson\u2019s disease: genetic and clinical studies from patients. Febs J 276(22):6455\u20136463","journal-title":"Febs J"},{"issue":"8","key":"8590_CR152","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/hmg\/ddr026","volume":"20","author":"A Dumitriu","year":"2012","unstructured":"Dumitriu A, Pacheco CD, Wilk JB, Strathearn KE, Latourelle JC, Goldwurm S, Pezzoli G, Rochet JC, Lindquist S, Myers RH (2012) Cyclin-G-associated kinase modifies alpha-synuclein expression levels and toxicity in Parkinson\u2019s disease: results from the GenePD Study. Hum Mol Genet 20(8):1478\u20131487","journal-title":"Hum Mol Genet"},{"key":"8590_CR153","first-page":"195","volume":"75","author":"SL Rhodes","year":"2011","unstructured":"Rhodes SL, Sinsheimer JS, Bordelon Y, Bronstein JM, Ritz B (2011) Replication of GWAS Associations for GAK and MAPT in Parkinson\u2019s Disease. Ann Hum Genet 75:195\u2013200","journal-title":"Ann Hum Genet"},{"issue":"5","key":"8590_CR154","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cellsig.2010.01.006","volume":"22","author":"I Carballo-Carbajal","year":"2010","unstructured":"Carballo-Carbajal I, Weber-Endress S, Rovelli G, Chan D, Wolozin B, Klein CL, Patenge N, Gasser T, Kahle PJ (2010) Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal 22(5):821\u2013827","journal-title":"Cell Signal"},{"issue":"1\u20133","key":"8590_CR155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000285509","volume":"7","author":"CH Hsu","year":"2010","unstructured":"Hsu CH, Chan D, Wolozin B (2010) LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins. Neurodegener Dis 7(1\u20133):68\u201375","journal-title":"Neurodegener Dis"},{"key":"8590_CR156","doi-asserted-by":"crossref","unstructured":"Gloeckner CJ, Boldt K, von Zweydorf F, Helm S, Wiesent L, Sarioglu H, Ueffing M (2010) Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-Terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J Proteome Res 9 (4):1738\u20131745","DOI":"10.1021\/pr9008578"},{"issue":"3","key":"8590_CR157","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pharmthera.2007.02.002","volume":"114","author":"RE Burke","year":"2007","unstructured":"Burke RE (2007) Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol Ther 114(3):261\u2013277","journal-title":"Pharmacol Ther"},{"issue":"34","key":"8590_CR158","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.2174\/138161209789649330","volume":"15","author":"GD Cuny","year":"2009","unstructured":"Cuny GD (2009) Kinase inhibitors as potential therapeutics for acute and chronic neurodegenerative conditions. Curr Pharm Des 15(34):3919\u20133939","journal-title":"Curr Pharm Des"},{"issue":"2","key":"8590_CR159","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(09)70363-1","volume":"9","author":"V Bonifati","year":"2010","unstructured":"Bonifati V (2010) Shaking the genome: new studies reveal genetic risk for Parkinson\u2019s disease. Lancet Neurol 9(2):136\u2013138","journal-title":"Lancet Neurol"},{"issue":"9766","key":"8590_CR160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","volume":"377","author":"MA Nalls","year":"2011","unstructured":"Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Arepalli S, Barker R, Ben-Shlomo Y, Berendse HW, Berg D, Bhatia K, de Bie RMA, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Bras JM, Brockmann K, Brooks J, Burn DJ, Charlesworth G, Chen HL, Chinnery PF, Chong S, Clarke CE, Cookson MR, Cooper JM, Corvol JC, Counsell C, Damier P, Dartigues JF, Deloukas P, Deuschl G, Dexter DT, van Dijk KD, Dillman A, Durif F, Durr A, Edkins S, Evans JR, Foltynie T, Gao JJ, Gardner M, Gibbs JR, Goate A, Gray E, Guerreiro R, Gustafsson O, Harris C, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang XM, Huber H, Hudson G, Hunt SE, Huttenlocher J, Illig T, Jonsson PV, Lambert JC, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, McNeill A, Moorby C, Moore M, Morris HR, Morrison KE, Mudanohwo E, O\u2019Sullivan SS, Pearson J, Perlmutter JS, Petursson H, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Sidransky E, Smith C, Spencer CCA, Stefansson H, Stockton JD, Strange A, Talbot K, Tanner CM, Tashakkori-Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden AG, Velseboer D, Vidailhet M, Walker R, van de Warrenburg B, Wickremaratchi M, Williams N, Williams-Gray CH, Winder-Rhodes S, Stefansson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW, Int Parkinson Dis Genomics C, Wellcome Trust Case-Control C (2011) Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet 377(9766):641\u2013649","journal-title":"Lancet"},{"issue":"1\u20134","key":"8590_CR161","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000334285","volume":"10","author":"S Fujioka","year":"2012","unstructured":"Fujioka S, Wszolek ZK (2012) Update on Genetics of Parkinsonism. Neurodegener Dis 10(1\u20134):257\u2013260","journal-title":"Neurodegener Dis"},{"issue":"11","key":"8590_CR162","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ncb1644","volume":"9","author":"H Plun-Favreau","year":"2007","unstructured":"Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J (2007) The mitochondrial protease HtrA2 is regulated by Parkinson\u2019s disease-associated kinase PINK1. Nat Cell Biol 9(11):1243\u2013U1263","journal-title":"Nat Cell Biol"},{"issue":"1002","key":"8590_CR163","first-page":"19","volume":"2","author":"K Shiba-Fukushima","year":"2012","unstructured":"Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, Hattori N (2012) PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci Rep 2(1002):19","journal-title":"Sci Rep"},{"issue":"7445","key":"8590_CR164","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12043","volume":"496","author":"SA Sarraf","year":"2013","unstructured":"Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW (2013) Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496(7445):372\u2013376","journal-title":"Nature"},{"issue":"11","key":"8590_CR165","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1089\/ars.2011.4312","volume":"17","author":"F Domenico Di","year":"2012","unstructured":"Di Domenico F, Sultana R, Ferree A, Smith K, Barone E, Perluigi M, Coccia R, Pierce W, Cai J, Mancuso C, Squillace R, Wiengele M, Dalle-Donne I, Wolozin B, Butterfield DA (2012) Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. Antioxid Redox Signal 17(11):1490\u20131506","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"8590_CR166","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-4159.2009.06024.x","volume":"109","author":"CJ Gloeckner","year":"2009","unstructured":"Gloeckner CJ, Schumacher A, Boldt K, Ueffing M (2009) The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3\/6 and MKK4\/7, in vitro. J Neurochem 109(4):959\u2013968","journal-title":"J Neurochem"},{"issue":"6","key":"8590_CR167","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1471-4159.2010.06568.x","volume":"112","author":"CH Hsu","year":"2010","unstructured":"Hsu CH, Chan D, Greggio E, Saha S, Guillily MD, Ferree A, Raghavan K, Shen GC, Segal L, Ryu H, Cookson MR, Wolozin B (2010) MKK6 binds and regulates expression of Parkinson\u2019s disease-related protein LRRK2. J Neurochem 112(6):1593\u20131604","journal-title":"J Neurochem"},{"issue":"4","key":"8590_CR168","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0896-6273(02)00821-8","volume":"35","author":"AH Kim","year":"2002","unstructured":"Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B, Birnbaum MJ, Chao MV (2002) Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35(4):697\u2013709","journal-title":"Neuron"},{"issue":"6928","key":"8590_CR169","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature01514","volume":"422","author":"S Hanash","year":"2003","unstructured":"Hanash S (2003) Disease proteomics. Nature 422(6928):226\u2013232","journal-title":"Nature"},{"key":"8590_CR170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1192\/bjp.180.2.131","volume":"180","author":"C Holmes","year":"2002","unstructured":"Holmes C (2002) Genotype and phenotype in Alzheimer\u2019s disease. Br J Psychiatry 180:131\u2013134","journal-title":"Br J Psychiatry"},{"issue":"4","key":"8590_CR171","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","volume":"84","author":"C Marras","year":"2013","unstructured":"Marras C, Lang A (2013) Parkinson\u2019s disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry 84(4):409\u2013415","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"8590_CR172","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-13405","volume":"13","author":"RF Itzhaki","year":"2008","unstructured":"Itzhaki RF, Wozniak MA (2008) Herpes simplex virus type 1 in Alzheimer\u2019s disease: the enemy within. J Alzheimers Dis 13(4):393\u2013405","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"8590_CR173","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archneur.55.2.151","volume":"55","author":"JQ Trojanowski","year":"1998","unstructured":"Trojanowski JQ, Lee VM (1998) Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol 55(2):151\u2013152","journal-title":"Arch Neurol"},{"issue":"1","key":"8590_CR174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M et al (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40(1):1\u20138","journal-title":"Neurology"},{"issue":"9557","key":"8590_CR175","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369(9557):218\u2013228","journal-title":"Lancet"},{"issue":"23","key":"8590_CR176","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1002\/pmic.200600499","volume":"6","author":"G Chemale","year":"2006","unstructured":"Chemale G, Morphew R, Moxon JV, Morassuti AL, LaCourse EJ, Barrett J, Johnston DA, Brophy PM (2006) Proteomic analysis of glutathione transferases from the liver fluke parasite, Fasciola hepatica. Proteomics 6(23):6263\u20136273","journal-title":"Proteomics"},{"issue":"1386","key":"8590_CR177","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1098\/rstb.1999.0461","volume":"354","author":"KH Fischbeck","year":"1999","unstructured":"Fischbeck KH, Lieberman A, Bailey CK, Abel A, Merry DE (1999) Androgen receptor mutation in Kennedy\u2019s disease. Philos Trans R Soc Lond B Biol Sci 354(1386):1075\u20131078","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"10","key":"8590_CR178","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1371\/journal.pone.0025545","volume":"6","author":"G Nardo","year":"2011","unstructured":"Nardo G, Pozzi S, Pignataro M, Lauranzano E, Spano G, Garbelli S, Mantovani S, Marinou K, Papetti L, Monteforte M, Torri V, Paris L, Bazzoni G, Lunetta C, Corbo M, Mora G, Bendotti C, Bonetto V (2011) Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS ONE 6(10):5","journal-title":"PLoS ONE"},{"issue":"1","key":"8590_CR179","first-page":"23","volume":"3","author":"T Ikeuchi","year":"1995","unstructured":"Ikeuchi T, Koide R, Onodera O, Tanaka H, Oyake M, Takano H, Tsuji S (1995) Dentatorubral-pallidoluysian atrophy (DRPLA). Molecular basis for wide clinical features of DRPLA. Clin Neurosci 3(1):23\u201327","journal-title":"Clin Neurosci"},{"key":"8590_CR180","first-page":"399","volume":"79","author":"S Tsuji","year":"1999","unstructured":"Tsuji S (1999) Dentatorubral-pallidoluysian atrophy (DRPLA): clinical features and molecular genetics. Adv Neurol 79:399\u2013409","journal-title":"Adv Neurol"},{"issue":"1","key":"8590_CR181","first-page":"40","volume":"17","author":"J Berciano","year":"2002","unstructured":"Berciano J, Infante J, Mateo I, Combarros O (2002) Hereditary ataxias and paraplegias: a clinicogenetic review]. Neurologia 17(1):40\u201351","journal-title":"Neurologia"},{"issue":"3","key":"8590_CR182","first-page":"1750","volume":"4","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4(3):1750\u20131172","journal-title":"Orphanet J Rare Dis"},{"key":"8590_CR183","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519\u2013550","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"8590_CR184","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/NRL.0b013e318167b93f","volume":"14","author":"R Bhidayasiri","year":"2008","unstructured":"Bhidayasiri R, Ling H (2008) Multiple system atrophy. Neurologist 14(4):224\u2013237","journal-title":"Neurologist"},{"issue":"10","key":"8590_CR185","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.freeradbiomed.2012.08.596","volume":"53","author":"A Cocciolo","year":"2012","unstructured":"Cocciolo A, Di Domenico F, Coccia R, Fiorini A, Cai J, Pierce WM, Mecocci P, Butterfield DA, Perluigi M (2012) Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics. Free Radic Biol Med 53(10):1868\u20131876","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"8590_CR186","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1371\/journal.pone.0028527","volume":"6","author":"M Thambisetty","year":"2011","unstructured":"Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund LO, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S (2011) Plasma biomarkers of brain atrophy in Alzheimer\u2019s disease. PLoS ONE 6(12):21","journal-title":"PLoS ONE"},{"key":"8590_CR187","first-page":"14","volume":"2013","author":"LH Guo","year":"2013","unstructured":"Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R (2013) Plasma Proteomics for the Identification of Alzheimer Disease. Alzheimer Dis Assoc Disord 2013:14","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"8590_CR188","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2012.11.010","volume":"534","author":"M Takano","year":"2013","unstructured":"Takano M, Yamashita T, Nagano K, Otani M, Maekura K, Kamada H, Tsunoda S, Tsutsumi Y, Tomiyama T, Mori H, Matsuura K, Matsuyama S (2013) Proteomic analysis of the hippocampus in Alzheimer\u2019s disease model mice by using two-dimensional fluorescence difference in gel electrophoresis. Neurosci Lett 534:85\u201389","journal-title":"Neurosci Lett"},{"issue":"24","key":"8590_CR189","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1002\/elps.201200251","volume":"33","author":"D Chaput","year":"2012","unstructured":"Chaput D, Kirouac LH, Bell-Temin H, Stevens SM Jr, Padmanabhan J (2012) SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells. Electrophoresis 33(24):3728\u20133737","journal-title":"Electrophoresis"},{"key":"8590_CR190","first-page":"17","volume":"2012","author":"VP Andreev","year":"2012","unstructured":"Andreev VP, Petyuk VA, Brewer HM, Karpievitch YV, Xie F, Clarke J, Camp D, Smith RD, Lieberman AP, Albin RL, Nawaz Z, El Hokayem J, Myers AJ (2012) Label-Free Quantitative LC-MS Proteomics of Alzheimer\u2019s Disease and Normally Aged Human Brains. J Proteome Res 2012:17","journal-title":"J Proteome Res"},{"key":"8590_CR191","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-59745-562-6_9","volume":"566","author":"R Sultana","year":"2009","unstructured":"Sultana R, Butterfield DA (2009) Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer\u2019s disease. Methods Mol Biol 566:123\u2013135","journal-title":"Methods Mol Biol"},{"issue":"4\u20135","key":"8590_CR192","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainresbull.2009.04.018","volume":"80","author":"IM Riederer","year":"2009","unstructured":"Riederer IM, Schiffrin M, Kovari E, Bouras C, Riederer BM (2009) Ubiquitination and cysteine nitrosylation during aging and Alzheimer\u2019s disease. Brain Res Bull 80(4\u20135):233\u2013241","journal-title":"Brain Res Bull"},{"issue":"23","key":"8590_CR193","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1742-4658.2010.07896.x","volume":"277","author":"T Alberio","year":"2010","unstructured":"Alberio T, Bossi AM, Milli A, Parma E, Gariboldi MB, Tosi G, Lopiano L, Fasano M (2010) Proteomic analysis of dopamine and alpha-synuclein interplay in a cellular model of Parkinson\u2019s disease pathogenesis. Febs J 277(23):4909\u20134919","journal-title":"Febs J"},{"issue":"2","key":"8590_CR194","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cccn.2005.03.028","volume":"357","author":"A Iuliis De","year":"2005","unstructured":"De Iuliis A, Grigoletto J, Recchia A, Giusti P, Arslan P (2005) A proteomic approach in the study of an animal model of Parkinson\u2019s disease. Clinica Chimica Acta 357(2):202\u2013209","journal-title":"Clinica Chimica Acta"},{"key":"8590_CR195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0074-7742(04)61010-5","volume":"61","author":"C Zabel","year":"2004","unstructured":"Zabel C, Klose J (2004) Influence of Huntington\u2019s disease on the human and mouse proteome. Int Rev Neurobiol 61:241\u2013283","journal-title":"Int Rev Neurobiol"},{"key":"8590_CR196","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0076-6879(06)12005-4","volume":"412","author":"K Mitsui","year":"2006","unstructured":"Mitsui K, Doi H, Nukina N (2006) Proteomics of polyglutamine aggregates. Methods Enzymol 412:63\u201376","journal-title":"Methods Enzymol"},{"issue":"5","key":"8590_CR197","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","volume":"45","author":"MA Sorolla","year":"2008","unstructured":"Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 45(5):667\u2013678","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"8590_CR198","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1074\/jbc.M804813200","volume":"284","author":"T Ratovitski","year":"2009","unstructured":"Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D\u2019Ambola J, Hou Z, Liang Y, Poirier MA, Hirschhorn RR, Graham R, Hayden MR, Cole RN, Ross CA (2009) Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem 284(16):10855\u201310867","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"8590_CR199","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainresbull.2011.01.012","volume":"88","author":"M Deschepper","year":"2012","unstructured":"Deschepper M, Hoogendoorn B, Brooks S, Dunnett SB, Jones L (2012) Proteomic changes in the brains of Huntington\u2019s disease mouse models reflect pathology and implicate mitochondrial changes. Brain Res Bull 88(2\u20133):210\u2013222","journal-title":"Brain Res Bull"},{"issue":"10","key":"8590_CR200","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4161\/cc.20423","volume":"11","author":"T Ratovitski","year":"2012","unstructured":"Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole RN, Ross CA (2012) Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 11(10):2006\u20132021","journal-title":"Cell Cycle"},{"issue":"12","key":"8590_CR201","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/pmic.201100380","volume":"12","author":"G Dong","year":"2012","unstructured":"Dong G, Callegari E, Gloeckner CJ, Ueffing M, Wang H (2012) Mass spectrometric identification of novel posttranslational modification sites in Huntingtin. Proteomics 12(12):2060\u20132064","journal-title":"Proteomics"},{"issue":"12","key":"8590_CR202","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1074\/mcp.M400094-MCP200","volume":"3","author":"K Fukada","year":"2004","unstructured":"Fukada K, Zhang F, Vien A, Cashman NR, Zhu H (2004) Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis. Mol Cell Proteomics 3(12):1211\u20131223","journal-title":"Mol Cell Proteomics"},{"key":"8590_CR203","doi-asserted-by":"crossref","unstructured":"Wei X, Herbst A, Ma D, Aiken J, Li L (2011) A quantitative proteomic approach to prion disease biomarker research: Delving into the glycoproteome. J Proteome Res 10(6):2687\u20132702","DOI":"10.1021\/pr2000495"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8590-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8590-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8590-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T17:41:25Z","timestamp":1564940485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8590-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":203,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["8590"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8590-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}